Magic mushroom therapy could help cut opioid dependence in chronic pain patients
NCT ID NCT05585229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination of psilocybin (the active ingredient in magic mushrooms) and talk therapy can help adults with chronic pain safely reduce or stop their opioid painkillers. Ten participants will receive one or two psilocybin sessions over 8 weeks, with follow-up for about 8 months. The goal is to see if the approach is safe, acceptable, and helps people taper off opioids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of British Columbia - Okanagan Campus
RECRUITINGKelowna, British Columbia, V1V 1V7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rewiring the brain to silence chronic pain — a bold psychological therapy is put to the test
- Honest placebos: can taking a sugar pill knowingly fight chronic pain?
- Digital therapy aims to help teens with chronic pain face their fears
- Ozone therapy put to the test: could it harm your eyes?
- Swiss launch national pain registry to uncover how treatments really work
- Mind over pain: imagining acupuncture may soothe chronic back pain